• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于与研究伦理委员会就通过软件降低风险进行沟通的案例研究:二次数据分析中记录链接的应用

Case study on communicating with research ethics committees about minimizing risk through software: an application for record linkage in secondary data analysis.

作者信息

Schmit Cason, Ferdinand Alva O, Giannouchos Theodoros, Kum Hye-Chung

机构信息

Population Informatics Lab, Texas A&M University, College Station, TX 77843, United States.

Department of Health Policy & Management, Texas A&M University, College Station, TX 77843, United States.

出版信息

JAMIA Open. 2024 Feb 29;7(1):ooae010. doi: 10.1093/jamiaopen/ooae010. eCollection 2024 Apr.

DOI:10.1093/jamiaopen/ooae010
PMID:38425705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10903982/
Abstract

OBJECTIVE

In retrospective secondary data analysis studies, researchers often seek waiver of consent from institutional Review Boards (IRB) and minimize risk by utilizing complex software. Yet, little is known about the perspectives of IRB experts on these approaches. To facilitate effective communication about risk mitigation strategies using software, we conducted two studies with IRB experts to co-create appropriate language when describing a software to IRBs.

MATERIALS AND METHODS

We conducted structured focus groups with IRB experts to solicit ideas on questions regarding benefits, risks, and informational needs. Based on these results, we developed a template IRB application and template responses for a generic study using privacy-enhancing software. We then conducted a three-round Delphi study to refine the template IRB application and the template responses based on expert panel feedback. To facilitate participants' deliberation, we shared the revisions and a summary of participants' feedback during each Delphi round.

RESULTS

11 experts in two focus groups generated 13 ideas on risks, benefits, and informational needs. 17 experts participated in the Delphi study with 13 completing all rounds. Most agreed that privacy-enhancing software will minimize risk, but regardless all secondary data studies have an inherent risk of unexpected disclosures. The majority (84.6%) noted that subjects in retrospective secondary data studies experience no greater risks than the risks experienced in ordinary life in the modern digital society. Hence, all retrospective data-only studies with no contact with subjects would be minimal risk studies.

CONCLUSION

First, we found fundamental disagreements in how some IRB experts view risks in secondary data research. Such disagreements are consequential because they can affect determination outcomes and might suggest IRBs at different institutions might come to different conclusions regarding similar study protocols. Second, the highest ranked risks and benefits of privacy-enhancing software in our study were societal rather than individual. The highest ranked benefits were facilitating more research and promoting responsible data governance practices. The highest ranked risks were risk of invalid results from systematic user error or erroneous algorithms. These societal considerations are typically more characteristic of public health ethics as opposed to the bioethical approach of research ethics, possibly reflecting the difficulty applying a bioethical approach (eg, informed consent) in secondary data studies. Finally, the development of privacy-enhancing technology for secondary data research depends on effective communication and collaboration between the privacy experts and technology developers. Privacy is a complex issue that requires a holistic approach that is best addressed through privacy-by-design principles. Privacy expert participation is important yet often neglected in this design process. This study suggests best practice strategies for engaging the privacy community through co-developing companion documents for software through participatory design to facilitate transparency and communication. In this case study, the final template IRB application and responses we released with the open-source software can be easily adapted by researchers to better communicate with their IRB when using the software. This can help increase responsible data governance practices when many software developers are not research ethics experts.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/a033083b7cc4/ooae010f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/c91db808cd27/ooae010f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/025e3cdbe42e/ooae010f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/702265ed835a/ooae010f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/a033083b7cc4/ooae010f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/c91db808cd27/ooae010f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/025e3cdbe42e/ooae010f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/702265ed835a/ooae010f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807a/10903982/a033083b7cc4/ooae010f4.jpg
摘要

目的

在回顾性二次数据分析研究中,研究人员常常寻求机构审查委员会(IRB)放弃同意要求,并通过使用复杂软件将风险降至最低。然而,对于IRB专家对这些方法的看法却知之甚少。为了促进关于使用软件降低风险策略的有效沟通,我们与IRB专家进行了两项研究,以便在向IRB描述软件时共同创建合适的语言。

材料与方法

我们与IRB专家进行了结构化焦点小组讨论,以征集关于益处、风险和信息需求问题的想法。基于这些结果,我们为使用隐私增强软件的一般研究开发了一份IRB申请模板和回复模板。然后,我们进行了三轮德尔菲研究,根据专家小组的反馈完善IRB申请模板和回复模板。为了便于参与者进行审议,我们在每轮德尔菲研究期间分享了修订内容和参与者反馈的摘要。

结果

两个焦点小组中的11位专家就风险、益处和信息需求提出了13条想法。17位专家参与了德尔菲研究,其中13位完成了所有轮次。大多数人认为隐私增强软件将使风险降至最低,但无论如何,所有二次数据分析研究都存在意外披露的固有风险。大多数(84.6%)指出,回顾性二次数据分析研究中的受试者所经历的风险并不比现代数字社会中日常生活所经历的风险更大。因此,所有不与受试者接触的仅涉及回顾性数据的研究都将是低风险研究。

结论

首先,我们发现一些IRB专家对二次数据分析研究中的风险看法存在根本分歧。这种分歧很重要,因为它们会影响判定结果,并且可能表明不同机构的IRB对于类似的研究方案可能会得出不同的结论。其次,在我们的研究中,隐私增强软件的最高排名风险和益处是社会性的而非个体性的。最高排名的益处是促进更多研究和推动负责任的数据治理实践。最高排名的风险是系统用户错误或错误算法导致无效结果的风险。这些社会考量通常更具公共卫生伦理的特征,与研究伦理的生物伦理方法不同,这可能反映了在二次数据分析研究中应用生物伦理方法(如知情同意)的困难。最后,二次数据分析研究的隐私增强技术的开发依赖于隐私专家与技术开发者之间的有效沟通与协作。隐私是一个复杂的问题,需要一种整体方法,最好通过设计时考虑隐私的原则来解决。隐私专家的参与很重要,但在这个设计过程中往往被忽视。本研究提出了通过参与式设计共同开发软件配套文档以吸引隐私社区参与的最佳实践策略,以促进透明度和沟通。在这个案例研究中,我们与开源软件一起发布的最终IRB申请模板和回复可以被研究人员轻松改编,以便在使用该软件时更好地与他们的IRB进行沟通。当许多软件开发人员不是研究伦理专家时,这有助于增加负责任的数据治理实践。

相似文献

1
Case study on communicating with research ethics committees about minimizing risk through software: an application for record linkage in secondary data analysis.关于与研究伦理委员会就通过软件降低风险进行沟通的案例研究:二次数据分析中记录链接的应用
JAMIA Open. 2024 Feb 29;7(1):ooae010. doi: 10.1093/jamiaopen/ooae010. eCollection 2024 Apr.
2
Communicating With Patients About Software for Enhancing Privacy in Secondary Database Research Involving Record Linkage: Delphi Study.与患者就涉及记录链接的二次数据库研究中增强隐私的软件进行沟通:德尔菲研究。
J Med Internet Res. 2020 Dec 15;22(12):e20783. doi: 10.2196/20783.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Identifying and prioritizing benefits and risks of using privacy-enhancing software through participatory design: a nominal group technique study with patients living with chronic conditions.通过参与式设计识别和优先考虑使用隐私增强软件的益处和风险:一项针对慢性病患者的名义群体技术研究。
J Am Med Inform Assoc. 2021 Jul 30;28(8):1746-1755. doi: 10.1093/jamia/ocab073.
5
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Building a Privacy, Ethics, and Data Access Framework for Real World Computerised Medical Record System Data: A Delphi Study. Contribution of the Primary Health Care Informatics Working Group.构建真实世界计算机化医疗记录系统数据的隐私、伦理与数据访问框架:德尔菲研究。初级卫生保健信息学工作组的贡献。
Yearb Med Inform. 2016 Nov 10(1):138-145. doi: 10.15265/IY-2016-035.
8
9
Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.知情同意的例外情况:机构审查委员会的观点——平衡对受试者的风险、社区咨询及未来方向
Acad Emerg Med. 2005 Nov;12(11):1050-5. doi: 10.1197/j.aem.2005.06.015.
10
360-degree Delphi: addressing sociotechnical challenges of healthcare IT.360 度德尔菲法:应对医疗信息技术的社会技术挑战。
BMC Med Inform Decis Mak. 2020 Jun 5;20(1):101. doi: 10.1186/s12911-020-1071-x.

引用本文的文献

1
AI Governance: A Challenge for Public Health.人工智能治理:公共卫生面临的挑战。
JMIR Public Health Surveill. 2024 Sep 30;10:e58358. doi: 10.2196/58358.

本文引用的文献

1
Assessing the impact of privacy-preserving record linkage on record overlap and patient demographic and clinical characteristics in PCORnet®, the National Patient-Centered Clinical Research Network.评估在国家以患者为中心的临床研究网络PCORnet®中,隐私保护记录链接对记录重叠以及患者人口统计学和临床特征的影响。
J Am Med Inform Assoc. 2023 Feb 16;30(3):447-455. doi: 10.1093/jamia/ocac229.
2
Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States.美国肝细胞癌 Medicare 患者的医疗费用。
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2327-2337.e9. doi: 10.1016/j.cgh.2022.11.015. Epub 2022 Nov 24.
3
A Position Statement on Population Data Science: The Science of Data about People.
关于人口数据科学的立场声明:关于人群的数据科学。
Int J Popul Data Sci. 2018 Feb 22;3(1):415. doi: 10.23889/ijpds.v3i1.415.
4
An Ethics Framework for Big Data in Health and Research.健康与研究领域大数据的伦理框架
Asian Bioeth Rev. 2019 Oct 1;11(3):227-254. doi: 10.1007/s41649-019-00099-x. eCollection 2019 Sep.
5
Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting.药物流行病学中的数据链接:呼吁进行严格的评估和报告。
Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):9-17. doi: 10.1002/pds.4924. Epub 2019 Nov 17.
6
Male factor infertility and risk of death: a nationwide record-linkage study.男性因素不孕与死亡风险:一项全国性的病历关联研究。
Hum Reprod. 2019 Nov 1;34(11):2266-2273. doi: 10.1093/humrep/dez189.
7
Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives.基于人群癌症登记的二次数据分析数据:方法学挑战与展望
Gesundheitswesen. 2020 Mar;82(S 01):S62-S71. doi: 10.1055/a-1009-6466. Epub 2019 Oct 29.
8
Predictors of Multiple Emergency Department Utilization Among Frequent Emergency Department Users in 3 States.3 个州中频繁使用急诊部门的患者多次急诊就诊的预测因素。
Med Care. 2020 Feb;58(2):137-145. doi: 10.1097/MLR.0000000000001228.
9
Cross Sector Data Sharing: Necessity, Challenge, and Hope.跨部门数据共享:必要性、挑战与希望。
J Law Med Ethics. 2019 Jun;47(2_suppl):83-86. doi: 10.1177/1073110519857325.
10
Patient perspectives on the linkage of health data for research: Insights from an online patient community questionnaire.患者对健康数据用于研究的看法:来自在线患者社区问卷调查的见解。
Int J Med Inform. 2019 Jul;127:9-17. doi: 10.1016/j.ijmedinf.2019.04.003. Epub 2019 Apr 6.